Madhumitha Pandiaraja
Papers
1
Total Citations
4
H-Index
1
About
Dr. Madhumitha Pandiaraja is a clinician-researcher advancing evidence-based decision-making in prostate cancer care, with a focus on integrating personalized risk tools into clinical practice. Her seminal work, "Utilisation and impact of predict prostate on decision‐making among clinicians and patients in a specialist tertiary referral centre," published in 2023, examines how the Predict Prostate prognostic model influences treatment choices for intermediate-risk prostate cancer patients. This retrospective cohort study, already garnering 4 citations, demonstrates her commitment to bridging the gap between computational risk prediction and real-world clinical utility. By analyzing how both clinicians and patients leverage personalized survival data to navigate the critical decision between radical treatment and active surveillance, Pandiaraja addresses a pressing need in urological oncology. Her research highlights the potential of decision aids to reduce decisional conflict and improve patient-centered outcomes. Based at a specialist tertiary referral center, she contributes to the growing body of literature on shared decision-making, ensuring that sophisticated predictive models translate into tangible benefits for patients facing complex treatment pathways. Her work underscores the importance of validating digital health tools in routine clinical settings.
Research Focus
Key Achievements
Top Papers
- 1